Health

Researchers have found a lymphatic route that carries fluid and waste away from the back of the mouse eye, a discovery that could reshape how glaucoma and macular degeneration are studied, though any treatment is a long way off.

London-based women’s health company will evaluate its Callavid drug delivery platform as part of a programme targeting antibiotic resistance.

AI systems make industries more efficient, but also pollute our air and water. Future regulation should take public health into account.

Phase 3 HIVEC® HEAT study presented at AUA 2026 highlights progress toward FDA registration and the potential for bladder-preserving treatment in high-risk NMIBC patients.

A first-in-human trial for a tampon-like intravaginal drug delivery platform arrives at a moment when England's newly published Women's Health Strategy is calling for exactly this kind of patient-centred innovation.

Cambridge-based imaging CRO brings together seven global experts to guide development of non-invasive AI endpoints.